News After Hikma and Mylan fail, Sandoz files Advair generic in U... FDA accepts Sandoz filing for Advair Diskus generic.
News FDA rejects Sunovion's nebulised COPD drug The US regulator has rejected Sunovion’s nebulised therapy for chronic obstructive pulmonary disease (COPD), leaving the company struggling to stay ahead of rivals.
News European regulators back Chiesi COPD triple therapy Chiesi takes on Seretide and other lung drugs with Trimbow.
News GSK gets short term boost as second US Advair generic reject... FDA rejects Hikma drug, regulator has "major" issue with Mylan's rival.
News GSK’s Relvar Ellipta comes out on top in real world study Encouraging results will support growth of its next generation respiratory treatment
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
